Sequential Compression Devices for Treatment of Restless Legs Syndrome
Primary Purpose
Restless Legs Syndrome
Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
AirCast Sequential Compression Device
Sponsored by
About this trial
This is an interventional treatment trial for Restless Legs Syndrome focused on measuring Restless Legs Syndrome, Sequential Compression Device, Sleep Quality, Quality of Life
Eligibility Criteria
Inclusion Criteria:
- Age greater than 17 years with a reliable diagnosis of RLS in accordance with the International Classification of Sleep Disorders, Revised Diagnostic and Coding Manual of the American Academy of Sleep Medicine.
Exclusion Criteria:
- Age less than 18 years
- Unstable medical conditions that may interfere with the requirements of the study (for example uncontrolled diabetes mellitus, symptomatic asthma, congestive heart failure with symptoms of pulmonary edema), and mental or physical limitations (including dementia) that would preclude data collection on questionnaires or wearing the SCD.
- Other medical conditions that would serve as exclusion criteria are those where increased venous or lymphatic return is undesirable. These specific conditions are known or suspected acute deep vein thrombosis, thrombophlebitis, severe congestive heart failure, pulmonary edema, severe arteriosclerosis, active infection such as gangrene, recent vein ligation or skin graft, or extreme deformity of the legs.
Sites / Locations
- Christopher Lettieri MD
Outcomes
Primary Outcome Measures
Severity of RLS Symptom Score; Epworth Sleepiness Scale; Quality of Life Scores (RLS-QLI)
Secondary Outcome Measures
Compliance with SCD therapy by patient diary; Patient subjective experience by personal comments.
Full Information
NCT ID
NCT00479531
First Posted
May 25, 2007
Last Updated
November 29, 2007
Sponsor
Walter Reed Army Medical Center
Collaborators
AirCast LLC
1. Study Identification
Unique Protocol Identification Number
NCT00479531
Brief Title
Sequential Compression Devices for Treatment of Restless Legs Syndrome
Official Title
Sequential Compression Devices for Treatment of Restless Legs Syndrome - a Prospective, Randomized, Sham-Controlled Study
Study Type
Interventional
2. Study Status
Record Verification Date
October 2007
Overall Recruitment Status
Completed
Study Start Date
September 2005 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
October 2007 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Walter Reed Army Medical Center
Collaborators
AirCast LLC
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to determine if sequential compression devices (SCD) when worn for an hour per day by patients suffering from Restless Legs Syndrome (RLS) are helpful for the improvement of the RLS symptoms and sleep.
Detailed Description
Restless legs syndrome (RLS) is a highly vexing problem manifested by sensory and motor symptoms that disrupt sleep onset or sleep maintenance. RLS is the second most common sleep disorder and occurs with an estimated prevalence of 10% in the general population. The sleep disruption results in daytime symptoms such as excessive daytime sleepiness (EDS) and mood changes. There are no consistently reliable treatment alternatives. There is an urgent need for new, innovative treatment strategies because available pharmacological treatments often stop working over time or are associated with unacceptable side effects. An effective nonpharmacological treatment would be a highly attractive alternative.
Anecdotally, patients have reported that use of sequential compression devices (SCD) prescribed for prophylaxis of deep vein thrombosis can have a positive effect on RLS symptoms. Because this nonpharmacological alternative is available, safe, and affordable, further investigation is warranted.
Simply stated, the null hypothesis is that SCD therapy does not have an impact on RLS symptoms.
Patients will be randomized to wearing SCDs or sham SCDs for an hour each day prior to the usual onset of the RLS symptoms. At baseline and at monthly follow-ups for 3 to 4 months, participants will complete questionnaires to assess the severity of the RLS symptoms, their daytime sleepiness, and the impact of the RLS on quality of life.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Restless Legs Syndrome
Keywords
Restless Legs Syndrome, Sequential Compression Device, Sleep Quality, Quality of Life
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
40 (Anticipated)
8. Arms, Groups, and Interventions
Intervention Type
Device
Intervention Name(s)
AirCast Sequential Compression Device
Primary Outcome Measure Information:
Title
Severity of RLS Symptom Score; Epworth Sleepiness Scale; Quality of Life Scores (RLS-QLI)
Time Frame
3 to 4 months
Secondary Outcome Measure Information:
Title
Compliance with SCD therapy by patient diary; Patient subjective experience by personal comments.
Time Frame
3 to 4 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age greater than 17 years with a reliable diagnosis of RLS in accordance with the International Classification of Sleep Disorders, Revised Diagnostic and Coding Manual of the American Academy of Sleep Medicine.
Exclusion Criteria:
Age less than 18 years
Unstable medical conditions that may interfere with the requirements of the study (for example uncontrolled diabetes mellitus, symptomatic asthma, congestive heart failure with symptoms of pulmonary edema), and mental or physical limitations (including dementia) that would preclude data collection on questionnaires or wearing the SCD.
Other medical conditions that would serve as exclusion criteria are those where increased venous or lymphatic return is undesirable. These specific conditions are known or suspected acute deep vein thrombosis, thrombophlebitis, severe congestive heart failure, pulmonary edema, severe arteriosclerosis, active infection such as gangrene, recent vein ligation or skin graft, or extreme deformity of the legs.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christopher Lettieri, MD
Organizational Affiliation
Pulmonary & Critical Care Medicine Service, Walter Reed Army Medical Center, Washington DC
Official's Role
Principal Investigator
Facility Information:
Facility Name
Christopher Lettieri MD
City
Sleep Disorders Center, Walter Reed Army Medical Center
State/Province
District of Columbia
ZIP/Postal Code
20307-5001
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
19017878
Citation
Lettieri CJ, Eliasson AH. Pneumatic compression devices are an effective therapy for restless legs syndrome: a prospective, randomized, double-blinded, sham-controlled trial. Chest. 2009 Jan;135(1):74-80. doi: 10.1378/chest.08-1665. Epub 2008 Nov 18.
Results Reference
derived
Learn more about this trial
Sequential Compression Devices for Treatment of Restless Legs Syndrome
We'll reach out to this number within 24 hrs